# Prognosis of Klebsiella ESBL Sepsis: Role of 2-HYDRoxy-myristate in Endotoxin Structure

> **NCT05193045** · — · UNKNOWN · sponsor: **Fondation Hôpital Saint-Joseph** · enrollment: 28 (actual)

## Conditions studied

- Klebsiella Infections

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05193045
- **Lead sponsor:** Fondation Hôpital Saint-Joseph
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-10-28
- **Primary completion:** 2021-11-28
- **Final completion:** 2023-12-31
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2023-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05193045

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05193045, "Prognosis of Klebsiella ESBL Sepsis: Role of 2-HYDRoxy-myristate in Endotoxin Structure". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT05193045. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*